Alex Massie Alex Massie

Drug War: Epic Fail

Lots happening on the Drug War front. First, the Latin American Commission on Drugs and Democracy, headed by former Presidents of Mexico, Colombia and Brazil, issues a report confirming that the tide of opinion in South America is turning against the Drug Warriors. In some respects the report simply states the obvious:

It is imperative to rectify the ‘war on drugs’ strategy pursued in the region over the past 30 years… Prohibitionist policies based on the eradication of production and on the disruption of drug flows as well as on the criminalization of consumption have not yielded the expected results. We are further than ever from the announced goal of eradicating drugs.

Who can doubt this? Ex-Presidents Cardoso, Gaviria and Zedillo suggest that drug use be treated as a public health not a criminal matter. This too seems a more sensible dedication of resources than a failed drug war that has crippled Colombia and shows every sign of crippling Mexico too. In other words, the questions of liberty and choice in this country and the USA also have serious consequences on the liberty of Latin American countries and the prospect of developing open, pluralist societies from Mexico to Patagonia.

Meanwhile, in the UK the government wants to withdraw benefits from drug users. It is hard to see how this will encourage a significant number of users and addicts (not the same thing, obviously) to seek treatment; by contrast it is quite easy to imagin how such a policy will increase crime and, consequently, add to the already high cost of drug enforcement – money that, again, could be more profitably spent elsewhere.

Already a subscriber? Log in

Keep reading with a free trial

Subscribe and get your first month of online and app access for free. After that it’s just £1 a week.

There’s no commitment, you can cancel any time.

Or

Unlock more articles

REGISTER

Comments

Don't miss out

Join the conversation with other Spectator readers. Subscribe to leave a comment.

Already a subscriber? Log in